D-99 | The Burden of Instent Restenosis in Patients with MASLD

This study examines the relationship between in-stent restenosis and metabolic-associated steatotic liver disease (MASLD), specifically focusing on non-alcoholic steatohepatitis cirrhosis (NASH cirrhosis), and its impact on clinical outcomes, including mortality, length of stay (LOS), and major adverse cardiovascular events (MACE).